Home › Funds › ARMISTICE CAPITAL, LLC › KURA

ARMISTICE CAPITAL, LLC position in KURA

KURA ONCOLOGY INC · Health Care

ARMISTICE CAPITAL, LLC reported holding 2,096,000 shares of KURA (KURA ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$22.4M, representing 0.31% of its reported portfolio and ranking #49 among its reported holdings. ARMISTICE CAPITAL, LLC has disclosed KURA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.10M sh
Reported value held$22.45M
Portfolio Weight0.31%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How ARMISTICE CAPITAL, LLC's KURA position evolved

ARMISTICE CAPITAL, LLC first disclosed a stake in KURA in Q3 2023 at 2,236,000 shares (US$20.4M). The position peaked in Q3 2024 at 2,658,000 shares, worth US$51.9M. Across 13 filings, ARMISTICE CAPITAL, LLC increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,096,000 shares valued at US$22.4M — a reduction of -1,582,000 shares quarter over quarter.. Notable position changes include a 118% increase in Q4 2024 (shares fell 24% over the following quarter), a 43% trim in Q3 2026 (shares fell 27% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.24M $20.39M New
Q4 2023 2.22M $31.98M Reduce
Q1 2024 2.05M $43.68M Reduce
Q2 2024 2.35M $48.39M Add
Q3 2024 2.66M $51.94M Add
Q4 2024 5.80M $50.52M Add
Q1 2025 6.57M $43.38M Add
Q2 2025 6.20M $35.77M Reduce
Q3 2025 4.67M $41.35M Reduce
Q4 2025 4.94M $51.29M Add
Q1 2026 3.74M $30.37M Reduce
Q2 2026 3.68M $40.35M Reduce
Q3 2026 2.10M $22.45M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KURA and 13F data

KURA (KURA ONCOLOGY INC) is a Health Care company. 25 other funds we track also report a position in KURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$94.1M), BVF INC/IL (US$92.7M), ALETHEA CAPITAL MANAGEMENT, LLC (US$23.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KURA

All KURA fund holders →

FAQ

How long has ARMISTICE CAPITAL, LLC held KURA?

ARMISTICE CAPITAL, LLC has disclosed KURA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ARMISTICE CAPITAL, LLC's current position in KURA?

As of Q3 2026, ARMISTICE CAPITAL, LLC holds 2.10M shares of KURA (KURA ONCOLOGY INC), valued at $22.45M, representing 0.31% of its reported portfolio and ranking #49.

Has ARMISTICE CAPITAL, LLC been buying or selling KURA?

In the latest 13F filing (Q3 2026), ARMISTICE CAPITAL, LLC reduced its position in KURA. The position peaked in Q3 2024 at 2.66M shares.

Which other funds hold KURA?

Other major institutional holders of KURA include MONTANOVA CAPITAL, LLC, BVF INC/IL, ALETHEA CAPITAL MANAGEMENT, LLC, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.